Artax Biopharma Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.16M
Latest Deal Amount
  • Investors
  • 4

Artax Biopharma General Information

Description

Developer of drugs designed to treat autoimmune and inflammatory diseases. The company's drugs eliminate harmful foreign pathogens while being tolerant of self-tissues and organs, enabling doctors to treat both the symptoms and the underlying disease with fewer side effects.

Contact Information

Website
www.artaxbiopharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1 Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

Artax Biopharma Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Artax Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 23-Feb-2021 $2.16M 000.00 Completed Clinical Trials - Phase 1
4. Later Stage VC (Series B3) 29-Apr-2020 000 000.00 0000 Completed Generating Revenue
3. Later Stage VC (Series B2) 08-Aug-2019 00000 000.00 00.000 Completed Generating Revenue
2. Early Stage VC (Series B) 22-Sep-2015 $10M $12M 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 10-Nov-2014 $2.01M $2.01M 00.000 Completed Generating Revenue
To view Artax Biopharma’s complete valuation and funding history, request access »

Artax Biopharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series B2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 8,750,452 $0.000100 $0.09 $1.14 $1.14 1x $1.14 28.61%
Series A 2,805,396 $0.000100 $1.77 $1.77 1x $1.45 11.18%
To view Artax Biopharma’s complete cap table history, request access »

Artax Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs designed to treat autoimmune and inflammatory diseases. The company's drugs eliminate harmful foreign
Drug Discovery
Cambridge, MA
10 As of 2020
000.00
0000000000 0 000.00

000000

uip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum d
0000 000000000
Seattle, WA
00 As of 0000
000.00
0000000000 0 000.00

00000 00

quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
0000000000000
Miramar, FL
00 As of 0000
00000
00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Artax Biopharma Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kineta Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
00000 0000000000 Formerly VC-backed Miramar, FL 00 00000 000000&0 00000
000 0000000000000 Formerly VC-backed Princeton, NJ 00 00.000 000000 - 000 00.000
000000000 00000000 Venture Capital-Backed Ottawa, Canada 00 00000 000000000000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
You’re viewing 5 of 28 competitors. Get the full list »

Artax Biopharma Executive Team (11)

Name Title Board Seat Contact Info
Andres Gagete Ph.D Chief Operating Officer
Christopher Vandeusen Ph.D Chief Scientific Officer
Balbino Alarcón Ph.D Co-Founder & Scientific Advisory Board Member
Richard Polisson MD Chief Medical Officer
Joseph Lobacki Chief Executive Officer, President & Board Member
You’re viewing 5 of 11 executive team members. Get the full list »

Artax Biopharma Board Members (10)

Name Representing Role Since
Alan Walts Ph.D Self Executive Chairman 000 0000
Balbino Alarcón Ph.D Artax Biopharma Co-Founder & Scientific Advisory Board Member 000 0000
Damià Tormo Ph.D Self Co-Founder & Board Member 000 0000
Gino Santini Self Board Member 000 0000
Javier Cogorro Columbus Venture Partners Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Artax Biopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Artax Biopharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Columbus Venture Partners Venture Capital Minority 000 0000 000000 0
Advent Life Sciences Venture Capital Minority 000 0000 000000 0
Henri Termeer Angel (individual) Minority 000 0000 000000 0
Pappas Capital Venture Capital Minority 000 0000 000000 0
To view Artax Biopharma’s complete investors history, request access »

Ready to get started?

Request a free trial